Clinical Implications of Selective Cyclooxygenase-2 Inhibition

Referenser

• Fries J F., Miller S R., Spitz P W., Williams C A., Hubert H B., Bloch D A. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterol 1989; 96: 647–55
   PubMed Web of Science ®Google Scholar
• Kleinknecht D. Diseases of the kidney caused by non steroidal anti-inflammatory drugs. Analgesic and NSAID-induced kidney disease, J H. Stewart. Oxford University Press, Oxford 1993; 160–79
   Google Scholar
• Vane J. Towards a better aspirin. Nature 1994; 367: 215–6
   PubMed Web of Science ®Google Scholar
• Sano H, Hla T, Maier J AM, Crofford L J., Case J P., Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptocoocai cell wall arthritis. J Clin Invest 1992; 89: 97–108
   PubMed Web of Science ®Google Scholar
• Crofford L J., Wilder R L., Ristimaki A P., et al. Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester and corticosteroids. J Clin Invest 1994; 93: 1095–101
   PubMed Web of Science ®Google Scholar
• Arend W P., Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33(3)305–15
   PubMed Web of Science ®Google Scholar
• Fries J F., Williams C A., Ramey D, Bloch D A. The relative toxicity of disease modifying antirheumatic drugs. Arthritis Rheum 1993; 36: 297–306
   PubMed Web of Science ®Google Scholar
• Fries J F. Reevaluating the therapeutic approach to rheumatoid arthritis: the “sawtooth” strategy. J Rheumatol 1990; 17(22)12–5
   Google Scholar
• Young A, Cox N, Dixie J, James D, Gough A, Gallivan S, et al. Early Rheumatoid Arthritis Study (ERAS). Report of first 506 patients. Arthritis Rheum 1991; 34(9)48
   Google Scholar
• Fuchs H, Kaye J J., Callahan L F., Nance P E., Pincus T. Evidence of significant radiographic damage in RA within the first two years of disease. J Rheumatol 1989; 16: 585–91
   PubMed Web of Science ®Google Scholar
• Emery P. Management of early inflammatory arthritis. Clinical Rheumatology. Balliere Tindall. 1992
   Google Scholar
• McAlindon T, Dieppe P. The medical management of osteoarthritis of the knee: an inflammatory issue?. Brit J Rheumatol 1990; 29: 471–3
   Google Scholar
• Brandt K D. Should osteoarthritis be treated with non-steroidal anti-inflammatory drugs?. Rheumatic Disease Clinics of North America 1993; 19(3)697–712
   Google Scholar
• Ledingham J, Regan M, Jones A, Doherty M. Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 1995; 54(l)53–8
   Google Scholar
• Lindblad S, Hedfors E. Arthroscopic and immunohislologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987; 30(10)1081–8
   Google Scholar
• Loose L D., De Oliveira R, Sipe J D., Franzblau C, Shanahan W R. A possible systemic component of osteoarthritis (OA): Elevated concentrations (by EL1SA) of C-reactive protein (CRP) in serum of OA patients and modulation by tenidap. Arthritis Rheum 1993; 36(Suppl 9)S166
   Google Scholar
• Kennedy T D., Plater Zyberk C, Partridge T A., Woodrow D F., Maini R N. Morphometric comparison of synovium from patients with osteoarthritis and rheumatoid arthritis. J Clin Pathol 1988; 41(8)847–52
   Google Scholar
• Williams H J., Ward J R., Egger M J., Neuner R, Brooks R H., Clegg D O., et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36(9)1196–206
   PubMedGoogle Scholar
• Bradley J D., Brandt K D., Katz B P., Kalasinski L A., Ryan S I. Comparison of an anti-inflammatory dose of ibuprofen. an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Eng J Med 1991; 325(2)125–7
   Google Scholar
• Dieppe P, Cushnaghan J, Jasani M K., McCrae F, Watt I. A two-year placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol 1993; 32(7)529–31
   Google Scholar
• Dekker J, Boot B, van der Woude L HV, Bijlsma J WJ. Pain and disability in osteoarthritis: a review of biobehavioural mechanisms. J Behav Med 1992; 15: 189–214
   PubMed Web of Science ®Google Scholar
• DeK Kr J, Tola P, Aufdemkampe G, Winckers M. Negative affect, pain and disability in osteoarthritis patients: the mediating role of muscle weakness. Behav Res Ther 1993; 31(2)203–6
   Google Scholar
• Angel J, Berenbaum F, Le Denmat C, Nevalainen T, Masliah J, Fournier C. Interleukin-1 induced prostaglandin E; biosyntheis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2. Eur J Biochem 1994; 226: 125–31
   PubMedGoogle Scholar